Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study

The Journal of Clinical Pharmacology(2025)10.1002/jcph.6138Source: DataRank Database

Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study is a research paper published in The Journal of Clinical Pharmacology (2025). On theSindex it has a DataRank of 0.345. It has been cited 9 times.

N/A

0.345DataRank · unranked

Scored on demand from live citation data

9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.66)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (30)

Bernhards Ogutu ORCID,Adoke Yeka ORCID,Sylvia Kusemererwa,Halidou Tinto ORCID,Andre Offianan Toure

Live enrichment

PubMed:39344281 PMC:PMC11771541 OpenAlex:https://openalex.org/W4402999330

Novartis

Medicines for Malaria Venture

Bill and Melinda Gates Foundation

FWCI

3.66

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcph.6138

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcph.6138

publisherhttps://accp1.onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.6138

journalhttps://doi.org/10.1002/jcph.6138

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39344281

Fields of Study

Malaria Research and ControlMosquito-borne diseases and controlDrug Transport and Resistance Mechanisms

MeSH Terms

Artemether, Lumefantrine Drug CombinationLumefantrineAdolescentAdultAgedAntimalarialsChildChild, PreschoolDrug CombinationsDrug InteractionsFemaleHumansMaleMiddle AgedProspective StudiesMalaria, FalciparumYoung Adult

Keywords

LumefantrineArtemether/lumefantrinePharmacokineticsMedicineMalariaProtein precipitationPlasmodium falciparumBlood samplingInternal medicinePharmacologyArtemisininImmunologyPlasmodium Falciparum MalariaGanaplacide

Sustainable Development Goals

SDG 0: Good health and well-being

Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study

FAIR Checklist

DataRank Breakdown

Authors (30)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)